DWP14012 tablet A
Sponsors
Daewoong Pharmaceutical Co. LTD.
Conditions
HealthyPhase 1 Study, Healthy Volunteers
Phase 1
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers
NCT04003441
Start: 2019-06-30End: 2019-08-31Target: 24Updated: 2019-07-01
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)
NCT04167267
Start: 2019-11-30End: 2020-01-31Target: 24Updated: 2019-11-22
Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)
NCT04185805
Start: 2019-12-14End: 2020-04-30Target: 24Updated: 2019-12-06
Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects
CompletedNCT05149274
Start: 2021-10-01End: 2021-10-26Updated: 2021-12-08